This enhanced expression strengthens the antigen-presenting capability of tumor cells, enabling better recognition by T cells and increasing IFN-γ release, ultimately leading to a more robust anti-tumor immune response [80,81,82]. This evidence concerns the gene IFNG and neoplasm.